US v Bishop

In January 2021, PATRICK CHARLES BISHOP, 54, pleaded guilty to the federal crime of conspiracy for fraudulently introducing adulterated drugs and misbranded drugs into interstate commerce.  A sentencing date has been set for May 5, 2021.

According to the plea agreement Bishop signed, Bishop owned and operated Patrick, LLC, an entity organized in Nevada.  Between 2015 and 2016, Bishop purchased, manufactured, labeled, marketed, sold, and distributed drug products purportedly containing a peptide called PNC-27.  PNC-27 has not been approved by the FDA for use in the United States as a drug to treat any disease, including cancer, nor has PNC-27 undergone clinical trials in the United States.  Bishop took steps to conceal these activities from the FDA and others.  Bishop used the business name Best Peptide Supply, LLC, to buy PNC-27 from GL Biochem, a manufacturer based in China, and used the business name Immuno Cellular Restoration Program, Inc., to sell PNC-27 products to others.  He described his distribution of PNC-27 products as part of a research effort, and made false representations to FDA personnel and others.

Bishop paid GL Biochem more than $600,000 for the product.  Bishop repeatedly assured the manufacturer that he would use the peptide solely for laboratory research purposes.  But instead, he used the peptide to make homemade suppositories in his kitchen in Birmingham, and at a warehouse he rented in Pelham.  The facilities were not sterile, and did not comply with current good manufacturing practices.  Customers who purchased suppositories from Bishop reported finding pieces of hair in their suppository packs.

Bishop marketed the PNC-27 drug products to alternative-medicine doctors, cancer patients, and others as an effective treatment for cancer.  Bishop sold PNC-27 drug products to Hope4Cancer, a holistic cancer treatment center with clinics in Mexico.  Bishop shipped the products to a location in California, and Hope4Cancer would use the products to treat patients at its Mexico clinics.  Bishop also sold PNC-27 drug products to patients and others in the United States.

The FDA investigated the case, which Assistant U.S. Attorney J.B. Ward is prosecuting.

If you believe that you may have been a victim of the alleged crimes, please contact Victim Assistance Specialist Tonja Benninger at 205-244-2093.

Next Court Date

The sentencing hearing for Bishop has been set for May 5, 2021, at 1:30 PM at the Hugo L. Black Courthouse in Birmingham, Alabama, before Judge Karen Bowdre.

Victim Impact Statement Form

Please submit any victim impact statements no later than April 23, 2021. 

Statement may be submitted via email to Tonja.Benninger@usdoj.gov or via mail to the following address:

United States Attorney’s Office, Northern District of Alabama

Attn: Tonja Benninger

1801 4^th Avenue North

Birmingham, AL 35203

Key Documents

Resources